Characteristics of femur morphology and proximal femur bone mineral density in Japanese females with bisphosphonate-related atypical femur fractures
- PMID: 39710724
- DOI: 10.1007/s00256-024-04857-3
Characteristics of femur morphology and proximal femur bone mineral density in Japanese females with bisphosphonate-related atypical femur fractures
Abstract
Objective: To determine which parameters, including femur morphology, proximal femur bone mineral density, or patient characteristics, are associated with bisphosphonate-related atypical femur fractures (AFFs) and to investigate the relationships between AFF location and these parameters.
Materials and methods: Sixteen females with a history of bisphosphonate use who presented with AFFs and 38 females without AFFs, even those with long-term bisphosphonate use of > 5 years, were compared. Patient characteristics; physique, gait ability, and history of pain and medication, were recorded. In terms of femur morphology, the mechanical lateral distal femoral articular angle (mLDFA), femoral bowing angle, femoral neck - shaft angle, and ratio of the femoral lateral cortex:neck width were measured via anteroposterior femur radiographs. Bone mineral density values of the femur neck, trochanter, inter, and Ward's triangle were used. Logistic regression analysis was conducted to determine independent factors for the AFF. In the 16 AFF patients, AFF locations were divided into 1: subtrochanteric, 2: proximal, 3: middle, and 4: distal femur diaphysis. The Spearman correlation coefficients (rs) between the AFF locations and the parameters were calculated.
Results: Logistic regression analysis revealed that the mLDFA and Ward's triangle values were significantly independently associated with AFF patients (odds ratios = 1.4 and 0.0, respectively). A more distal AFF location was significantly correlated with a shorter body height and greater BMI (rs = -0.69 and 0.67, respectively).
Conclusion: An evaluation combining the mLDFA and Ward's triangle value could be used to predict the risk of bisphosphonate-related AFFs. Body height or BMI may be helpful for predicting AFF location.
Keywords: Atypical femur fracture; Bisphosphonate; Bone mineral density; Femur morphology; Lateral bowing femur.
© 2024. The Author(s), under exclusive licence to International Skeletal Society (ISS).
Conflict of interest statement
Declarations. Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Conflict of interest: All authors declare that they have no conflict of interest.
Similar articles
-
Lateral Cortical Thickening and Bone Heterogeneity of the Subtrochanteric Femur Measured With Quantitative CT as Indicators for Early Detection of Atypical Femoral Fractures in Long-Term Bisphosphonate Users.AJR Am J Roentgenol. 2017 Oct;209(4):867-873. doi: 10.2214/AJR.17.17938. Epub 2017 Aug 10. AJR Am J Roentgenol. 2017. PMID: 28796551
-
Critical differences between subtrochanteric and diaphyseal atypical femoral fractures: analyses of 51 cases at a single institution in Korean population.Arch Osteoporos. 2018 May 3;13(1):53. doi: 10.1007/s11657-018-0457-1. Arch Osteoporos. 2018. PMID: 29725835
-
Bone cross-sectional geometry is not associated with atypical femoral fractures in Asian female chronic bisphosphonate users.Bone. 2015 Oct;79:170-5. doi: 10.1016/j.bone.2015.06.003. Epub 2015 Jun 9. Bone. 2015. PMID: 26067179
-
[Pathogenesis of atypical femoral fracture].Clin Calcium. 2016 Jan;26(1):73-9. Clin Calcium. 2016. PMID: 26728533 Review. Japanese.
-
Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.J Clin Endocrinol Metab. 2020 May 1;105(5):1682-99. doi: 10.1210/clinem/dgz295. J Clin Endocrinol Metab. 2020. PMID: 31867670 Free PMC article.
References
-
- Reid IR. Extensive expertise in endocrinology: Osteoporosis management. Eur J Endocrinol. 2022;187:65–80. https://doi.org/10.1530/EJE-22-0574 . - DOI
-
- Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348:1535–41. https://doi.org/10.1016/s0140-6736(96)07088-2 . - DOI - PubMed
-
- Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological management of osteoporosis in postmenopausal women: An endocrine society* Clinical practice guideline. J Clin Endocrinol Metab. 2019;104:1595–622. https://doi.org/10.1210/jc.2019-00221 . - DOI - PubMed
-
- Black DM, Geiger EJ, Eastell R, et al. Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med. 2020;383:743–53. https://doi.org/10.1056/NEJMoa1916525 . - DOI - PubMed - PMC
-
- Buitendijk SKC, van de Laarschot DM, Smits AAA, et al. Trabecular bone score and hip structural analysis in patients with atypical femur fractures. J Clin Densitom. 2019;22:257–65. https://doi.org/10.1016/j.jocd.2018.03.005 . - DOI - PubMed
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical